Drug Type Small molecule drug |
Synonyms Hexafluronium Bromide, NSC-19477, MYLAXEN |
Target |
Action inhibitors |
Mechanism CC chemokine inhibitors(CC chemokine inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseWithdrawn |
First Approval Date- |
Regulation- |
Molecular FormulaC36H42Br2N2 |
InChIKeyWDEFPRUEZRUYNW-UHFFFAOYSA-L |
CAS Registry317-52-2 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D04435 | Hexafluorenium bromide | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Fasciculation | United States | - |





